177 related articles for article (PubMed ID: 18978817)
1. Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer.
Wang T; Chen YH; Hong H; Zeng Y; Zhang J; Lu JP; Jeansonne B; Lu Q
Oncogene; 2009 Jan; 28(4):555-64. PubMed ID: 18978817
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.
Lu Q; Dobbs LJ; Gregory CW; Lanford GW; Revelo MP; Shappell S; Chen YH
Hum Pathol; 2005 Oct; 36(10):1037-48. PubMed ID: 16226102
[TBL] [Abstract][Full Text] [Related]
3. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
Lu JP; Zhang J; Kim K; Case TC; Matusik RJ; Chen YH; Wolfe M; Nopparat J; Lu Q
Mol Cancer; 2010 Nov; 9():304. PubMed ID: 21106062
[TBL] [Abstract][Full Text] [Related]
4. δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.
Nopparat J; Zhang J; Lu JP; Chen YH; Zheng D; Neufer PD; Fan JM; Hong H; Boykin C; Lu Q
Oncogene; 2015 Mar; 34(12):1542-52. PubMed ID: 24727894
[TBL] [Abstract][Full Text] [Related]
5. Intratumor δ-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression.
Li M; Nopparat J; Aguilar BJ; Chen YH; Zhang J; Du J; Ai X; Luo Y; Jiang Y; Boykin C; Lu Q
Oncogene; 2020 May; 39(22):4358-4374. PubMed ID: 32313227
[TBL] [Abstract][Full Text] [Related]
6. delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles.
Zeng Y; Abdallah A; Lu JP; Wang T; Chen YH; Terrian DM; Kim K; Lu Q
Mol Cancer; 2009 Mar; 8():19. PubMed ID: 19284555
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer.
Burger MJ; Tebay MA; Keith PA; Samaratunga HM; Clements J; Lavin MF; Gardiner RA
Int J Cancer; 2002 Jul; 100(2):228-37. PubMed ID: 12115574
[TBL] [Abstract][Full Text] [Related]
8. δ-Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma.
Huang F; Chen J; Wang Z; Lan R; Fu L; Zhang L
Oncol Rep; 2018 Feb; 39(2):809-817. PubMed ID: 29251319
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer.
Wang B; Zhou R; Wu J; Kim H; Kim K
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119741. PubMed ID: 38697304
[TBL] [Abstract][Full Text] [Related]
11. Identification of E2F1 as a positive transcriptional regulator for delta-catenin.
Kim K; Oh M; Ki H; Wang T; Bareiss S; Fini ME; Li D; Lu Q
Biochem Biophys Res Commun; 2008 May; 369(2):414-20. PubMed ID: 18302937
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Winn-Deen E; Oliver J; Fisher HA; Kaufman RP; Ross JS
Cancer; 2001 Dec; 92(11):2786-95. PubMed ID: 11753952
[TBL] [Abstract][Full Text] [Related]
13. δ-Catenin Regulates Spine Architecture via Cadherin and PDZ-dependent Interactions.
Yuan L; Seong E; Beuscher JL; Arikkath J
J Biol Chem; 2015 Apr; 290(17):10947-57. PubMed ID: 25724647
[TBL] [Abstract][Full Text] [Related]
14. Rarity of DNA sequence alterations in the promoter region of the human androgen receptor gene.
Cabral DF; Santos A; Ribeiro ML; Mesquita JC; Carvalho-Salles AB; Hackel C
Braz J Med Biol Res; 2004 Dec; 37(12):1789-94. PubMed ID: 15558185
[TBL] [Abstract][Full Text] [Related]
15. Kaiso interacts with p120-catenin to regulate β-catenin expression at the transcriptional level.
Liu Y; Dong QZ; Wang S; Xu HT; Miao Y; Wang L; Wang EH
PLoS One; 2014; 9(2):e87537. PubMed ID: 24498333
[TBL] [Abstract][Full Text] [Related]
16. Human Vav1 expression in hematopoietic and cancer cell lines is regulated by c-Myb and by CpG methylation.
Ilan L; Katzav S
PLoS One; 2012; 7(1):e29939. PubMed ID: 22253833
[TBL] [Abstract][Full Text] [Related]
17. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
[TBL] [Abstract][Full Text] [Related]
18. Identification of extracellular delta-catenin accumulation for prostate cancer detection.
Lu Q; Zhang J; Allison R; Gay H; Yang WX; Bhowmick NA; Frelix G; Shappell S; Chen YH
Prostate; 2009 Mar; 69(4):411-8. PubMed ID: 19116988
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases.
Lu Q; Aguilar BJ; Li M; Jiang Y; Chen YH
Hum Genet; 2016 Oct; 135(10):1107-16. PubMed ID: 27380241
[TBL] [Abstract][Full Text] [Related]
20. δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate Cancer.
Shrestha N; Shrestha H; Ryu T; Kim H; Simkhada S; Cho YC; Park SY; Cho S; Lee KY; Lee JH; Kim K
Mol Cells; 2018 Apr; 41(4):320-330. PubMed ID: 29629558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]